(0.05%) 5 519.75 points
(0.12%) 39 891 points
(0.13%) 19 776 points
(-0.07%) $81.57
(0.46%) $2.82
(-0.23%) $2 339.10
(0.19%) $29.58
(0.55%) $1 007.30
(0.08%) $0.932
(-0.10%) $10.52
(0.02%) $0.788
(-0.85%) $87.25
-8.69% $ 7.57
Live Chart Being Loaded With Signals
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems...
Stats | |
---|---|
Dzisiejszy wolumen | 88 246 |
Średni wolumen | 916 540 |
Kapitalizacja rynkowa | 225.22M |
EPS | $-0.0614 ( Q1 | 2024-05-15 ) |
Następna data zysków | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-14.56 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0530 (0.70%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Pimblett Emily | Sell | 5 000 | Restricted Stock Units |
2024-06-18 | Pimblett Emily | Buy | 5 000 | Common Stock |
2024-06-20 | Pimblett Emily | Sell | 1 245 | Common Stock |
2024-04-05 | Morisset Valerie | Buy | 17 847 | Common Stock |
2024-04-05 | Morisset Valerie | Sell | 17 847 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
35.79 |
Last 78 transactions |
Buy: 17 606 902 | Sell: 12 026 668 |
Wolumen Korelacja
Eliem Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
THCP | 0.945 |
AGBA | 0.919 |
IZEA | 0.895 |
NISN | 0.893 |
STCN | 0.89 |
CSTE | 0.886 |
RILY | 0.881 |
CADL | 0.877 |
RILYZ | 0.864 |
CHCI | 0.859 |
10 Najbardziej negatywne korelacje | |
---|---|
ICLK | -0.946 |
VAXX | -0.922 |
LINK | -0.868 |
WVVI | -0.861 |
APDN | -0.851 |
SECO | -0.848 |
MRNS | -0.847 |
INTC | -0.84 |
KOPN | -0.834 |
DHCNI | -0.832 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eliem Therapeutics, Inc. Korelacja - Waluta/Towar
Eliem Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.300 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.720 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.05 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej